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ABSTRACT   
 
BACKGROUND: Pulmonary tuberculosis is one of the most 
important health concerns. Pulmonary fungal infections have 
clinical and radiological characteristics similar to tuberculosis 
which may be easily misdiagnosed as tuberculosis. This study 
aimed to evaluate tuberculosis (TB) status and coinfection of TB 
with pulmonary fungal infections in patients referred to reference 
laboratory of health centers Ghaemshahr city during 2007-2017. 
METHODS: This cross-sectional study was conducted during 
eleven years, between 2007-2017, on 3577 patients with suspected 
TB referred to health centers of Ghaemshahr City. For isolation, 
sputum smear preparation and Ziehl-Neelson staining in 
companying with microscopy direct observation and KOH 10% + 
white Calcofluor staining was used. The culture of fungi was 
performed on Sabouraud Dextrose agar, Czapek and chrome agar 
media. Then, data were analyzed using SPSS software (version 16) 
through Student's t-test, Fisher test, and Odds Ratio. P values 
<0.05 were considered statistically significant. 
RESULTS: Of 3577 patients, 10731 smears were prepared, 3.6% 
(n=130) of patients were identified as smear-positive pulmonary 
tuberculosis, 86.4% (n=3090) were smear negative and 10% 
(n=357) drug-resistant TB. The mean age of patients was 48±1.8 
years. With increasing age, the prevalence of TB has increased 
which was statistically significant (P value <0.05). Prevalence of 
tuberculosis in the age group over than 57 years in males and 
females had an ascending trend. Amongst the positive tuberculosis 
patients, 16/130 cases (12.3%) had the coinfection of TB with 
fungi microorganisms.   
CONCLUSION: Our findings showed the coinfection of fungi 
agents in patients with tuberculosis that should be considered. 
KEYWORDS: Coinfection, Mycobacterium tuberculosis, 
Pulmonary Fungal Infection 
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INTRODUCTION  
 
Pulmonary tuberculosis is a major cause of 
mortality attributed to the Mycobacterium 
tuberculosis complex globally, tuberculosis (TB) 
is placed amongst the top 10 causes of death 
worldwide (1). More than 95% of pulmonary 
tuberculosis cases have been reported from 
developing countries, particularly from Asia, 
Africa, the Middle East and Latin America which 
have limited diagnostic and therapeutic 
equipment(2,3). The annual TB deaths have 
reported about three million people that two and 
one million of those have belonged to the adults 
and children, respectively(4). Currently, the 
incidence rate of smear-positive pulmonary 
tuberculosis in our country (Iran) is the main 
index in the measurement of tuberculosis 
situation. Tuberculosis incidence rate is counted 
as dividing the number of new cases of disease 
within a year in one hundred thousand 
populations (5). However, its incidence is highly 
variable by region. For example, in the United 
States, the annual incidence is less than 5 cases 
per 100,000 people, while in sub-Saharan Africa 
and Asia reaches to hundreds of cases per 100,000 
people. The occurrence of TB is global. In 2016, 
the leading number of new TB cases was related 
to Asia, with 45% of new cases, followed by 
Africa, with 25% of new cases. In 2016, 87% of 
new TB cases were from 30 high TB burden 
countries. Seven countries (India, Indonesia, 
China, Philippines, Pakistan, Nigeria, and South 
Africa) were responsible for 64% of the new TB 
cases (6).  
Many risk factors such as war, immigration, 
family history of close contact with TB patients, 
social status, age, poverty, male gender, HIV 
infection, smoking, asthma and homelessness had 
the significant role in the risk of developing 
tuberculosis (7). 
Multi-drug resistant TB (MDR-TB) is 
described as tuberculosis with resistance to both 
rifampicin and isoniazid drugs (8,9). XDR-TB is a 
form of TB which is resistant to at least four of 
the core anti-TB drugs. XDR-TB involves 
resistance to the two most dominant anti-TB 
drugs, isoniazid, and rifampicin, also known as 
multidrug-resistance (MDR-TB), in addition to 
resistance to any of the fluoroquinolones (such as 
levofloxacin or moxifloxacin) and to at least one 
of the three injectable second-line drugs 
(amikacin, capreomycin or kanamycin) (10). Data 
obtained from the latest anti-TB drug resistance 
surveillance show that 4.1% of new and 19% of 
previously treated TB cases in the world are 
expected to rifampicin or multidrug-resistant 
tuberculosis (MDR/RR-TB), based on estimations 
in 2016, about 600 000 new cases of MDR/RR-
TB emerged worldwide which caused 240 000 
deaths in the same year, especially in Asia. Also, 
nearly 6.2% of extensively drug-resistant TB 
(XDR-TB) was described, as well as, one million 
children developed TB and 250 000 children died 
of TB in 2016 (11).  
Sistan and Baluchestan, Khorasan, 
Mazandaran, Gilan, West Azerbaijan, East 
Azerbaijan, Ardabil, Kurdistan, and Khuzestan 
provinces are the regions of Iran with the high 
burden of tuberculosis (12). Based on the reports 
of Iranian Centre for Disease Control and 
Prevention, the number of confirmed MDR-TB 
cases has increased from 8 in 2003 to 41 in 2015 
(13). 
Filamentous saprophyte fungi have a wide 
distribution in nature, and their spore is abundant 
in the air and the transmission of infection occurs 
always through inhalation (14).  The extensive use 
of antibiotics and steroids has recently caused a 
widespread prevalence of fungal pulmonary 
infection. Some factors such as 
immunodeficiency, chronic diseases, malignancy 
are involved in worsening the diseases and these 
fungal pulmonary infections may be formed 
primary and secondary in TB infection (15). In 
many cases, missed fungal pulmonary infection 
due to lack of specific clinical manifestations 
causes a high rate of morbidity and mortality (16). 
Candida albicans is the most prevalent fungal 
organism with the ability to causing infections, 
including slight mucocutaneous infection to 
invasive forms with affecting the multiple organs, 
sever Candida infections occur in 
immunosuppressive patients (17). The prevalence 
              
           Tuberculosis Status…                                                                                  Mohammed R. et al.                      
 
 
DOI:  http://dx.doi.org/10.4314/ejhs.v28i6.2 
 
685
of 15-32% was reported in different studies of 
pulmonary tuberculosis coinfection with Candida 
(18). Four types of fungi: Aspergillus niger, A. 
fumigatus, Histoplasma capsulatum and 
Cryptococcus neoformans are main causes of 
malignant infections in lungs in patients affected 
by pulmonary tuberculosis (19). 
Aspergillus is an airborne/saprophyte agent 
that does not normally form disease, but in 
immune-compromised people and also in 
individuals with damaged lungs such as those 
who have had TB can cause the disease. Because 
the symptoms of chronic pulmonary aspergillosis 
are very similar to TB symptoms that physician 
often misdiagnoses it, unfortunately, the infection 
can grow steadily and undetectably for years, and 
its treatment is too late successfully. Therefore, 
timely diagnosis of fungal diseases is of great 
importance in treating patients (20). Due to the 
lack of comprehensive studies about the 
epidemiology of TB and coinfection pulmonary 
fungal infections in patients from the Mazandaran 
province, Iran, this study aimed to evaluate the 
tuberculosis status and coinfection of pulmonary 
fungal infections in patients with TB referred to 
reference laboratory of health centers in 
Ghaemshahr City during 2007-2017. 
 
METHODS 
 
Patients and samples: In this cross-sectional 
study, information was extracted from medical 
records of patients with TB infection. The medical 
records were filled and completed by the educated 
and trained personnel in the health center of 
Ghaemshahr City. Three consecutive sputum 
samples were collected in a sterile dry wide-
necked, leak-proof container from each of the 
patients with suspected pulmonary tuberculosis 
referred to the TB health centers of Ghaemshahr 
City during eleven years (between 2007-2017), 
and they were transferred to Sari Medical School 
for microbiology and mycology staining. The 
patients referred were from urban and rural 
regions, prisoners, literate and illiterate. The study 
population included all new cases, recurrent TB 
and MDR-TB patients.  
In this study, recurrent tuberculosis (TB), defined 
as TB that recurs after a patient has been 
considered cured. Also, patients who were not 
treated by first and second lines of anti TB drugs 
and still have signs and symptoms of tuberculosis 
and their smear were not negative considered as 
MDR-TB. For determination of sample size, 
Krejcie-morgan-sample-size-table was used. 
Based on the age variable, patients were 
categorized in 8 age groups (0-10, 11-20, 21-30, 
31-40, 41-50, 51-60, 61-70, and 71-80). 
Specimen processing and bacteriological 
procedures: The laboratory used of direct smear 
microscopy accompanying with culture in the 
diagnosis of Tuberculosis. Sputum specimens 
were homogenized with equal volumes of 50 mM 
NaOH containing 0.5% N-acetyl-l-cysteine 
(NALC) and decontaminated with 10% sodium 
hydroxide, and then incubated at 37 °C. Also, 
some of the specimens were used for Ziehl-
Neelson staining (21). And also, direct 
examination for identification of filamentous 
fungi was applied using staining white Calcoflura 
technique+10% KOH through fluorescence 
microscopy with fungi culture in Sabouraud 
Dextrose agar medium containing 
chloramphenicol (SC) with incubating at 30°C for 
a week. Aspergillus species were identified using 
sub-culture on Czapek agar medium with 
diagnosis keys provided by Raper and Fennell 
previously. Diagnosis of yeasts was conducted by 
sub-culture on Chrom agar/Corn meal agar with 
Tween 80% and the germ tube test. Clinical and 
radiographic parameters were evaluated in all 
patients with tuberculosis. The co-infection cases 
of fungi with TB were reported according to 8 
different age groups. 
The quality control of the laboratory in the 
diagnosis of tuberculosis was carried out by 
annual quality control samples. As well as for 
further quality, the positive and negative sputum 
samples were transferred to the capital of 
Mazandaran Province (Sari). 
Ethical considerations: Because the study had a 
laboratory base, did not require the specific 
ethical considerations. However, all patients' 
rights were respected, such as the non-disclosure 
of their names. 
Statistical analysis: Data were analyzed using 
SPSS software (version 16) by Fisher's exact 
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test, and Odds Ratio. P values of less than 0.05 
were regarded as statistically significant. 
 
RESULTS  
 
From a total of 3577 patients with suspected TB 
during ten-years, 10731 smears were prepared. Of 
which 30(0.28%), 53(0.49%) and 19(0.18%) had 
respectively, one, two and three positive sputum 
smears. Also, 3.6% (n=130) of patients were 
identified as smear-positive pulmonary 
tuberculosis. And, 86.4% (n=3090) were smear-
negative pulmonary tuberculosis and 10% 
(n=357) were drug-resistant TB. Based on the 
findings of this study, the prevalence of 
tuberculosis in males was more than in females. 
And, the percentages of male and female with 
smear-positive tuberculosis were reported as 70% 
(91/130) and 30% (39/130), respectively. And, a 
significant statistical correlation was seen 
between gender and infection with TB (P-value 
<0.05). With increasing age, the prevalence of TB 
has increased, and this increase was statistically 
significant (P-value <0.05). The mean age of 
patients was 48±1.8 years and the minimum and 
maximum ages of patients were 10 and 86 years, 
respectively. The highest incidence was found in 
patients aged 36-68 years. It should be noted that 
the prevalence of tuberculosis in the age group 
over 57 years in both sexes had an ascending 
trend. Totally, the trend of tuberculosis from 2007 
to 2017 has a descending trend. The most 
symptoms of pulmonary TB in patients included 
in this study were cough, consistent fever, low-
grade fevers, night sweats, loss of appetite, and 
chest pain. 
In total, 48/10731 smears (0.44%) were 
positive for fungi infections. Amongst the positive 
tuberculosis patients, 16/130 cases (12.3%) had 
the coinfection of Mycobacterium tuberculosis 
with fungi microorganisms such as Candida 
albicans, Aspergillus fumigatus and, A. flavus. 
Ten out of 16 cases (62.5%) had the coinfection 
Aspergillus spp., with TB and 6 /12(37.5%) had 
the coinfection of Candida spp., with TB. As 
shown in Figure 1, the most prevalence of 
coinfection of fungi with TB (31.2%, 5/16) was in 
the age group of 41-50 years. With increasing age, 
the prevalence of coinfection TB with fungi 
infection has increased, and this increase was 
statistically significant (P value <0.05), because 
56.2%( 9/16) cases of coinfection were in patients 
greater than 40 years.  The most frequency of 
coinfection of Aspergillus spp., with TB (18.7%, 
3/16) was observed in age groups (41-50) and 
(51-60). And also, the most occurrence of 
coinfection of Candida spp., with TB (12.5%, 
2/16) was reported in the age groups of (21-30) 
and (41-50). In this study, amongst Aspergillus 
spp., A. fumigatus (43.75%) was the most 
frequent, and non-albicans spp. (25%) were the 
most common species amongst Candida spp. 
recovered from sputum samples. The coinfection 
of TB with fungal infections in males (15.4%) 
was higher than in females (14.7%), (P=0.01). 
Overall, tuberculosis could be a risk factor for 
fungal infection (Odds ratio=.32; 95% CI for 
OR=.10 to 1.00). The further details related to the 
prevalence of fungi spp, are listed in the Table1.   
 
Table1: Prevalence of fungi spp. in male and females based on the age groups.  
 
No. of patients with 
coinfection of fungi with TB 
 
Aspergillus spp.(Total=10) 
 
C. albicans spp.(Total=6) 
 
T-test 
A. 
fumigatus 
A. flavus   A. niger C. 
albicans 
None C. 
albicans spp. 
P-
value 
Male(n=91)  5(31.25%) 1(6.25%) 1(6.25%) 1(6.25%) 3(18.75%) 0.01 
Female(n=49)  2(12.5%) 1(6.25%) 0(0%) 1(6.25%) 1(6.25%) 0.61 
Total  7(43.75%) 2(12.5%) 1(6.25%) 2(12.5%) 4(25%)  - 
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Fig. 1. Prevalence of fungi spp. in male and female based on the age groups. 
 
DISCUSSION 
 
Tuberculosis is a serious health and treatment 
problem which occurs in all countries over the 
world, but in terms of condition, its prevalence is 
very different, the distribution of incidence and 
prevalence rate of TB is not the same in all areas 
of our country (Iran). A study conducted by 
Manzouri, et al. showed that, between 2005 and 
2006 years, the percentage of new smear-positive 
pulmonary TB prevalence was 11.1% (22). In a 
study conducted by Gholami, et al., during 2002-
2007 years, in Uremia (Iran) showed that among 
248 positive patients for tuberculosis, 151 and 97 
cases were respectively smear-positive and smear 
negative. Also, 66.1% of those were male. In line 
to their findings, our results revealed that the 130 
cases were smear positive and 46.5% of patients 
were male (23). In contrast to our results, in a 
study carried out by Mousavi, et al., during 2001-
2007 years in Kashan, among the 196 TB patients, 
67% of patients were pulmonary tuberculosis, and 
most of the patients with pulmonary tuberculosis 
were female (24). In addition, in a study 
conducted by Ebrahim Zadeh, et al., during 1995-
2006 years showed that among 840 patients in 
Birjand, 46.2% were male and 70% cases were 
pulmonary tuberculosis (25). 
In a study conducted by Rafiee, et al., in 
Golestan Province(Iran), during 2005-2006, on 
patients with extra and pulmonary TB, their 
findings showed that the number of the males 
with smear-positive pulmonary tuberculosis 
was higher than females. And also the incidence 
of TB was increased with age (26). Similar to our 
results, the ratio of males/females was higher. A 
significant correlation was found between the 
incidence of TB with increasing the age. But in 
contrary to our results, the rate of pulmonary 
tuberculosis cases was very higher. This 
difference can probably be attributed to the fact 
that the samples in their studies were collected 
from all parts of the Golestan province, but our 
samples were collected only from Ghaemshahr 
City (located in Mazandaran province), and they 
counted both pulmonary and extrapulmonary TB 
together, while we considered only pulmonary 
TB, of course. It should be noted that the province 
of Golestan alongside Sistan and Baluchestan are 
two provinces with the high burden of TB than 
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other regions of Iran (27). In agreement to several 
studies conducted in different parts of our country 
(Iran), the prevalence of TB in males was higher 
than in females, which can be attributed to the 
more attendance of male in the community and 
more close contacts with carriers/patients and the 
risk factors that lead to tuberculosis (28). Also, in 
this study, the mean age of patients was 48±1.8 
years. The highest incidence was found in patients 
aged 36-68 years. The prevalence of tuberculosis 
in the age group of over 57 years in both sexes 
had an ascending trend. These findings are 
consistent with reports from other studies. This 
ascending trend of tuberculosis prevalence in aged 
people is due to reactivation of latent TB in these 
patients (29). 
Totally, the trend of tuberculosis from 2007 
to 2017 has a descending trend. However, in 
contrast to our results, a study conducted in 
Singapore, did not show a decreasing trend in the 
number of TB patients from 2006 to 2010. 
Similarly, from 2011 to 2013, this increased 
number of TB cases probably resulted from 
Medical tourism and the high flood of foreign 
workers to Singapore (30). 
The prevalence of opportunistic fungal 
infections has recently increased, which normally 
incapable of causing disease in healthy persons. 
While they are the potential pathogens in 
immunocompromised individuals, patients with 
underlying diseases, broad consumption of 
antibiotics, impairments of immunity in 
pulmonary tuberculosis patients (31). In this 
study, as mentioned in the results section, A. 
fumigatus, A. flavus and A. niger plus non-
albicans spp., were the most common species 
recovered from sputum samples. In line with our 
findings, in the study conducted by N.M. Osman 
and et al., in Egypt, in 2012 on 50 tuberculosis 
patients, A. fumigatus was reported as the most 
frequent Aspergillus spp., followed by A. niger 
and A. flavus, while other fungal species were not 
detected (15). Also, other studies from over the 
world reported the Aspergillus spp., as the 
predominant fungi in patients suspected of 
pulmonary tuberculosis (32-34). The leading 
Aspergillus spp., detected from sputum in this 
study was A. fumigates, while Razmpa et al., 
reported the higher prevalence for A. flavus (35). 
In the study conducted at Patna Medical College 
Hospital, Bihar (India), in 2011 to 2012, 75 
sputum samples were collected from patients 
suspected of tuberculosis. Their results indicated 
that the Candida albicans was isolated in 44.4% 
of cases followed by A. niger with a prevalence of 
33.3% (36), as well as others reported the C. 
albicans as the most frequent fungi spp (37). The 
correlation between co-existence of Candida 
infections and pulmonary tuberculosis has 
increased concern during recent years (38). In 
contrary to their findings, our results showed the 
Aspergillus spp., as the most predominant fungi 
and also, amongst Aspergillus spp., A. fumigatus 
was predominant. The findings of a study carried 
out by Speirs et al., showed that the A. fumigatus 
was the common agent of chronic respiratory 
infections such as M. tuberculosis. This is 
consistent with our results. In addition, a variety 
of studies have shown that pulmonary 
colonization of potentially pathogenic 
microorganisms such as Aspergillus in some 
patients with COPD, cystic fibrosis or 
tuberculosis is associated with high mortality and 
inappropriate prognosis (39). The results of this 
study indicated that the situation of tuberculosis 
disease could be one of the risk factors for fungal 
infections. Several studies also have shown that A. 
fumigatus like M. tuberculosis has colonized 
respiratory tract of patients with respiratory 
complications (40). 
As presented in our study, the coinfection of 
TB with fungal infections in males was higher 
than in females. This is possibly attributed to the 
fact that the males are more susceptible to 
infection than females owing to their higher 
exposure to the surrounding as stated in a study 
conducted by Bansod et al., in which fungal 
infection was reported higher in males than in 
females (19). 
Regarding the role of fungal agents in 
exacerbation of tuberculosis and the lack of 
improvement in tuberculosis symptoms such as 
chronic cough, sputum or occasional hemoptysis 
following completion of anti-tuberculosis 
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chemotherapy, and miss diagnosis with 
tuberculosis, it is necessary to pay more attention 
to this topic. It would be used of more accurate 
molecular techniques in the diagnosis of fungal 
agents especially in coinfection of those with 
pulmonary tuberculosis. 
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